Kim Han-joo
Kim Han-joo is a journalist at Yonhap News Agency in Seoul, South Korea. Their reporting focuses on biotechnology and pharmaceutical companies, particularly in the context of the COVID-19 pandemic. They have reported on topics such as vaccine development, virus variants like omicron, and company strategies to combat new strains. Han-joo's work often includes interviews with executives from major pharmaceutical companies like Moderna Inc., Pfizer Inc., Johnson & Johnson, and AstraZeneca.
10%
The Daily's Verdict
This author has a poor reputation for journalistic standards and is not considered a reliable news source.
Bias
0%
Examples:
No current examples available.
Conflicts of Interest
0%
Examples:
No current examples available.
Contradictions
0%
Examples:
No current examples available.
Deceptions
0%
Examples:
No current examples available.
Recent Articles
North Korea's Unsanitary Retaliation: Trash-Filled Balloons Carry Parasites and Health Risks Amidst Escalating Tensions with South Korea
Broke On: Monday, 24 June 2024North Korea retaliates against South Korean activists' leaflet campaigns with trash-filled balloons carrying parasites and human waste, escalating tensions between the two Koreas. Experts suggest potential health risks from the debris and criticize North Korea's disregard for international norms.